Skip to main content

Jordi Lozano Torres

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Jordi Lozano Torres

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Personal Investigador para Grupo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Alba Santos Ortega, José Antonio Barrabés Riu, Maria Vidal Burdeus, Jose Fernando Rodríguez Palomares, Laura Gutierrez García-Moreno, Antonia Sambola Ayala, Nuria Rivas Gandara, Jordi Perez Rodon, Angeles Rojas Lopez, Antonio Rodríguez Sinovas, Teresa González Alujas, Begoña Benito Villabriga, Gisela Teixido Tura, Antonia Pijuan Domenech, Enric Domingo Ribas, Victor Gonzalez Fernandez, Guillem Casas Masnou, David Aluja Gonzalez, Bernat Serra Creus, Vicente Serra García, Gerard Marti Aguasca, Neus Bellera Gotarda, Aitor Uribarri Gonzalez, Imanol Otaegui Irurueta, Jordi Bañeras Rius, Bruno García del Blanco, Ruperto Olivero Soldevila, Elisabet Miro Casas, Marisol Ruiz Meana, Mireia Andres Villarreal, Jordi Lozano Torres, Ana Belén Méndez Fernández, Berta Miranda Barrio, Gerard Oristrell Santamaria, Pau Rello Sabaté, Toni Soriano Colomé, Jaume Francisco Pascual, Aleix Olivella San emeterio, Sara Delgado Tomás, Aroa Ruiz Muñoz, Javier Inserte Igual, Personal Investigador para Grupo Cardiovascular, Javier Limeres Freire, Irene Buera Surribas, Ruben Fernández Galera, Raul Aguilar Lopez, Alvaro Calabuig Goena, Lydia Dux-Santoy Hurtado, Laura Galián Gay, Laura Dos Subirá, Maria Nazarena Pizzi, Filipa Xavier De Carvalho Negrao Valente, Andrea Guala
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00758
Duration: 01/01/2022 - 30/06/2025

Impact of an exercise-based rehabilitation program in patients with Marfan syndrome on physical, psychological and cardiovascular health

IP: -
Collaborators: Laura Gutierrez García-Moreno, Jordi Lozano Torres, Alba Gómez Garrido, Lydia Dux-Santoy Hurtado, PATRICIA LAUNOIS OBREGÓN, Filipa Xavier De Carvalho Negrao Valente, Raul Aguilar Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI21/00448
Duration: 01/01/2022 - 30/06/2026

Rehab+

IP: Jordi Lozano Torres
Collaborators: -
Funding agency: EIT- European Institute of Innovation & Technolog
Funding: 55865.85
Reference: REHAB+_EIT HEALTH2020
Duration: 01/01/2021 - 31/12/2022

Evaluación de la efectividad del seguimiento mediante app de pacientes atendidos en una Consulta de Rehabilitación y Control de Riesgo Cardiovascular

IP: Ignacio Ferreira González
Collaborators: Aida Ribera Sole, Jordi Lozano Torres, Gerard Oristrell Santamaria, Javier Limeres Freire
Funding agency: Fundación Merck Salud
Funding: 10000
Reference: MERCK2019/IFERREIRA
Duration: 02/12/2019 - 02/12/2021

Related news

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

Related professionals

Arnau Peñalver Piñol

Arnau Peñalver Piñol

Predoctoral researcher
Epidemiology and Public Health
Read more
Rocio  Lecegui  Alfonso

Rocio Lecegui Alfonso

Administration and Management
Growth and Development
Read more
Lara Aguilera  Castro

Lara Aguilera Castro

Main researcher
Physiology and Pathophysiology of the Digestive Tract
Read more
Irene Portas Torres

Irene Portas Torres

Research technician
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.